Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crofelemer for Gut Microbiome in HIV+ and Healthy Volunteers
NCT04192487Phase 4Completed
- Sponsor
- Napo Pharmaceuticals
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of crofelemer in HIV-associated diarrhea, sponsored by Napo Pharmaceuticals. Started Oct 2019; status: completed.
02
Drugs
crofelemer
03
Conditions
HIV-associated diarrhea
Beyond the preview
Go deeper on NCT04192487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04192487.